Barclay Hedge Fund Index tape-recorded a 6th month-to-month successive gain, of 0.37% in June and 4.41% YTD.
Hedge funds continue their favorable streak in the market through the year in general, and in the month of June in specific by getting 0.37 percent, according to the Barclay Hedge Fund Index put together by BarclayHedge. Leading the pack for the month was Healthcare and Biotechnology sector with gains of 5.32 percent. The index has remained in the green for the previous 11 of the 12 months and in 2017 it is currently up by 4.41 percent.
Total 13 from 17 sub-indices tape-recorded development in June. Health care and Biotechnology (5.32 percent), Pacific Rim equities (1.85 percent) and Equity Long Bias (0.85 percent) were leading gainers in the index. Innovation (1.21 percent), Global Macro (0.74 percent) and Distressed Securities (0.13 percent) underperformed the index and were leading losers.
This year has been best for the Healthcare and Biotechnology sector which tape-recorded the greatest gain of (11.92 percent), followed by Technology (11.08 percent) and Emerging Markets (8.24 percent). International Macro has been the greatest loser in the index this month and this year it has tape-recorded a decrease of 0.15 percent. The total strength in the index was supported by the continued rally of United States equity market and huge returns from particular market sectors.
Sol Waksman, creator and President of BarclayHedge, stated: “2017 has been an intriguing year for the hedge fund market. While the United States market has stayed strong, current attention has been focused in emerging markets and Europe. We’ve seen favorable returns in duration of traditionally low volatility; it will be fascinating to see how markets carry out if volatility gets.”